Deletion of key genes within the TNF signaling, IFN-γ signaling, and antigen presentation pathways provided protection for tumor cells against CD8+ T cell-mediated killing and impaired antitumor immune responses in vivo (Kearney et al., 2018). The gene discussed is CD8A; the disease is neoplasm.